Risk factors | Odds ratio (95% CI) | ||||||
---|---|---|---|---|---|---|---|
Macrovascular Complication | Microvascular Complication | ||||||
CAD | Ischemic Strok | PAD | Retinopathy | Nephropathy | Neuropathy | Diabetic Foot | |
Sex | Â | Â | Â | Â | Â | Â | Â |
 Male |  |  |  |  | 0.43(0.20-0.91)* |  |  |
 Female | reference |  |  |  |  |  |  |
Age group (years) | Â | Â | Â | Â | Â | Â | Â |
 ≤ 20 |  |  |  | 4.55(0.64-31.92) |  |  |  |
 21–40 |  |  |  | 0.39(0.11 − 1.30) |  |  |  |
 > 40 | reference |  |  |  |  |  |  |
Educational Level | Â | Â | Â | Â | Â | Â | Â |
 Illiterate |  |  | 1.43(0.13-16.25) | 2.03(0.48-8.55) | 5.86(1.06–32.27)* |  | 4.18(1.13–15.47)* |
 Primary School |  |  | 1.45(0.12-18.06) | 1.03(0.25-4.23) | 4.96(0.88-27.98) |  | 1.89(0.52-6.92) |
 Secondary School |  |  | 0.28(0.01-9.32) | 0.97(0.19 − 4.9) | 0.85(1.13–47.10) |  | 0.78(0.91-16.61) |
 University and above | reference |  |  |  |  |  |  |
Place of Residence | Â | Â | Â | Â | Â | Â | Â |
 Urban |  | 0.37(0.09-1.43) | 0.47(0.11-1.98) |  |  |  |  |
 Rural | reference |  |  |  |  |  |  |
Family income | Â | Â | Â | Â | Â | Â | Â |
 Low income |  | 0.07(0.01-0.64)* | 0.07(0.01-0.66)* |  |  |  |  |
 Middle income |  | 0.06(0.00-1.10) | 0.04(0.00-0.87)* |  |  |  |  |
 High income | reference |  |  |  |  |  |  |
Occupation | Â | Â | Â | Â | Â | Â | Â |
 Unemployed |  |  |  | 2.97(1.27–6.93)* |  |  |  |
 Employed | reference |  |  |  |  |  |  |
BMI Categories | Â | Â | Â | Â | Â | Â | Â |
 Obese | 2.88(1.22–6.85)* | 4.84(1.39–16.89)* | 3.67(1.02–13.18)* | 2.86(1.23–6.66)* |  | 2.60(1.23–5.46)* | 1.73(0.85-3.54) |
 Non-Obese | reference |  |  |  |  |  |  |
HbA1c | Â | Â | Â | Â | Â | Â | Â |
 Uncontrol (> 7%) | 1.53(0.66-3.58) | 1.94(0.23-3.78) | 2.78(0.19-3.28) | 1.23(0.55 − 2.70) | 1.65(0.79-3.44) | 1.26(0.63-2.53) | 1.21(0.60-2.45) |
 Control (≤ 7%) | reference |  |  |  |  |  |  |
Adherence to DM treat | Â | Â | Â | Â | Â | Â | Â |
 No | 5.60(1.96–16.02)** | 12.10(2.34–62.48)** | 7.80(1.61–37.81)* | 7.60(3.00-19.22)** | 8.26(3.22–21.21)** | 4.79(2.20-10.39)** | 1.32(0.65-2.69) |
 Yes | reference |  |  |  |  |  |  |
Family History of DM | Â | Â | Â | Â | Â | Â | |
 No |  |  |  | 0.32(0.14-0.72)** |  |  | 0.54(0.28-1.05) |
 Yes | reference |  |  |  |  |  |  |
Bp Control | Â | Â | Â | Â | Â | Â | Â |
 No | 2.88(1.23–6.76)* | 7.62(2.01–28.84)** | 13.69(2.81–66.82)** | 2.36(1.05–5.25)* | 2.54(1.19–5.44)* |  | 3.66(1.71–7.83)** |
 Yes | reference |  |  |  |  |  |  |
Type of DM | Â | Â | Â | Â | Â | Â | Â |
 Type I | 3.11(1.33–7.28)** | 3.57(0.96-13.23) | 3.59(0.88-14.64) |  |  | 1.09(0.52-2.25) | 3.88(1.95–7.75)** |
 Type II | reference |  |  |  |  |  |  |
Duration of DM (years) | Â | Â | Â | Â | Â | Â | |
 < 10 | 0.20(0.06-0.74)* | 0.08(0.01-0.67)* | 0.10(0.01-0.88)* | 0.28(0.08-0.91)* | 0.26(0.09-0.75)* | 0.46(0.16-1.28) | 0.48(0.17-1.32) |
 10-≤20 | 0.50(0.17-1.43) | 0.48(0.11-2.18) | 0.51(0.10-2.59) | 0.15(0.04-0.45)** | 0.41(0.15-1.09) | 0.20(0.07-0.53)** | 0.44(0.17-1.14) |
 > 20 | reference |  |  |  |  |  |  |
Follow-up with physician | Â | Â | Â | Â | Â | Â | |
 No | 1.56(0.68 − 3.60) | 1.49(0.42-5.35) | 1.93(0.50-7.52) | 4.63(2.14–10.01)* | 2.51(1.20–5.25)* | 2.66(1.30–5.44)** | 2.30(1.13–4.68)* |
 Yes | reference |  |  |  |  |  |  |
Lipid Lowering Medication | Â | Â | Â | Â | Â | Â | |
 No |  | 3.18(0.86-11.70)* | 3.23(0.84-12.40)* |  |  |  |  |
 Yes | reference |  |  |  |  |  |  |